Tim Obara joins Genenta

Friday 13 May 2022
Genenta Science SpA
Appointee name
Tim Obara


Italy-based Genenta Science SpA has appointed Tim Obara as head of business development to help identify partnership opportunities for its clinical stage gene therapy programme for cancer. Mr Obara joins from the Gene Therapy Program at the University of Pennsylvania, US where he was executive director of research operations.

Genenta announced the appointment on 9 May 2022.

Copyright 2022 Evernow Publishing Ltd